NCT00114010View on ClinicalTrials.gov

Experimental Vaccine for Malaria

PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

April 1, 2005

Primary Completion Date

December 22, 2006

Study Completion Date

December 22, 2006

Conditions
Malaria
Interventions
DRUG

AMA1/Alhydrogel

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00114010 - Experimental Vaccine for Malaria | Biotech Hunter | Biotech Hunter